BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 16493118)

  • 1. Interleukin-6 g.-174G>C promoter polymorphism is associated with obesity in the EPIC-Potsdam Study.
    Klipstein-Grobusch K; Möhlig M; Spranger J; Hoffmann K; Rodrigues FU; Sharma AM; Klaus S; Pfeiffer AF; Boeing H
    Obesity (Silver Spring); 2006 Jan; 14(1):14-8. PubMed ID: 16493118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of interleukin 6 -174G>C polymorphism on obesity-related metabolic disorders in people with excess in body weight.
    Goyenechea E; Parra D; Martínez JA
    Metabolism; 2007 Dec; 56(12):1643-8. PubMed ID: 17998015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RGS2 C1114G polymorphism and body weight gain in hypertensive patients.
    Sartori M; Ceolotto G; Dorigatti F; Mos L; Santonastaso M; Bratti P; Papparella I; Semplicini A; Palatini P;
    Metabolism; 2008 Mar; 57(3):421-7. PubMed ID: 18249218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between interleukin 6 promoter polymorphism at position -174, IL-6 serum levels, and the risk of relapse/recurrence in polymyalgia rheumatica.
    Boiardi L; Casali B; Farnetti E; Pipitone N; Nicoli D; Cantini F; Macchioni P; Bajocchi G; Catanoso MG; Pulsatelli L; Consonni D; Salvarani C
    J Rheumatol; 2006 Apr; 33(4):703-8. PubMed ID: 16583473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between plasma IL-6, the IL6 -174G>C gene variant and the metabolic syndrome in type 2 diabetes mellitus.
    Stephens JW; Hurel SJ; Lowe GD; Rumley A; Humphries SE
    Mol Genet Metab; 2007 Apr; 90(4):422-8. PubMed ID: 17123852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interleukin 6-174G/C polymorphism is associated with indices of obesity in men.
    Berthier MT; Paradis AM; Tchernof A; Bergeron J; Prud'homme D; Després JP; Vohl MC
    J Hum Genet; 2003; 48(1):14-9. PubMed ID: 12560873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A common polymorphism in the interleukin-6 gene promoter is associated with overweight.
    Wernstedt I; Eriksson AL; Berndtsson A; Hoffstedt J; Skrtic S; Hedner T; Hultén LM; Wiklund O; Ohlsson C; Jansson JO
    Int J Obes Relat Metab Disord; 2004 Oct; 28(10):1272-9. PubMed ID: 15303107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Body composition changes after laparoscopic adjustable gastric banding: what is the role of -174G>C interleukin-6 promoter gene polymorphism in the therapeutic strategy?
    Di Renzo L; Carbonelli MG; Bianchi A; Iacopino L; Fiorito R; Di Daniele N; De Lorenzo A
    Int J Obes (Lond); 2012 Mar; 36(3):369-78. PubMed ID: 21730965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-6 gene polymorphism -174G/C influences plasma lipid levels in women.
    Henningsson S; Håkansson A; Westberg L; Baghaei F; Rosmond R; Holm G; Ekman A; Nissbrandt H; Eriksson E
    Obesity (Silver Spring); 2006 Nov; 14(11):1868-73. PubMed ID: 17135599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-6 (IL-6) -572C-->G promoter polymorphism is associated with type 2 diabetes risk in Koreans.
    Koh SJ; Jang Y; Hyun YJ; Park JY; Song YD; Shin KK; Chae JS; Kim BK; Ordovas JM; Lee JH
    Clin Endocrinol (Oxf); 2009 Feb; 70(2):238-44. PubMed ID: 18573122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of interleukin-6 (-174G>C) promoter polymorphism with risk of squamous cell esophageal cancer and tumor location: an exploratory study.
    Upadhyay R; Jain M; Kumar S; Ghoshal UC; Mittal B
    Clin Immunol; 2008 Aug; 128(2):199-204. PubMed ID: 18502691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. -174G/C IL-6 gene promoter polymorphism predicts therapeutic response to TNF-α blockers.
    Di Renzo L; Bianchi A; Saraceno R; Calabrese V; Cornelius C; Iacopino L; Chimenti S; De Lorenzo A
    Pharmacogenet Genomics; 2012 Feb; 22(2):134-42. PubMed ID: 22158445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The -174 G/C polymorphism of the interleukin-6 gene promoter and essential hypertension in an elderly Italian population.
    Pola R; Flex A; Gaetani E; Pola P; Bernabei R
    J Hum Hypertens; 2002 Sep; 16(9):637-40. PubMed ID: 12214260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BMI modifies associations of IL-6 genotypes with insulin resistance: the Framingham Study.
    Herbert A; Liu C; Karamohamed S; Liu J; Manning A; Fox CS; Meigs JB; Cupples LA
    Obesity (Silver Spring); 2006 Aug; 14(8):1454-61. PubMed ID: 16988089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interleukin-6 -174G/C promoter polymorphism is not associated with endometriosis in South Indian women.
    Bhanoori M; Babu KA; Deenadayal M; Kennedy S; Shivaji S
    J Soc Gynecol Investig; 2005 Jul; 12(5):365-9. PubMed ID: 15979549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin 6-174 G/C promoter gene polymorphism in centenarians: no evidence of association with human longevity or interaction with apolipoprotein E alleles.
    Capurso C; Solfrizzi V; D'Introno A; Colacicco AM; Capurso SA; Semeraro C; Capurso A; Panza F
    Exp Gerontol; 2004 Jul; 39(7):1109-14. PubMed ID: 15236771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increase in interleukin-6 following arterial injury is related to insulin resistance, the -174G-->C polymorphism and complex plaque morphology.
    Marso SP; House JA; Hopkins PJ
    Int J Immunogenet; 2006 Oct; 33(5):347-54. PubMed ID: 16984279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The IL-6 gene G-174C polymorphism related to health indices in Greek primary school children.
    Dedoussis GV; Manios Y; Choumerianou DM; Yiannakouris N; Panagiotakos DB; Skenderi K; Zampelas A
    Obes Res; 2004 Jul; 12(7):1037-41. PubMed ID: 15292466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-6 polymorphism is associated with more aggressive prostate cancer.
    Tan D; Wu X; Hou M; Lee SO; Lou W; Wang J; Janarthan B; Nallapareddy S; Trump DL; Gao AC
    J Urol; 2005 Aug; 174(2):753-6. PubMed ID: 16006970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The increased plasma C-reactive protein and interleukin-6 levels in patients undergoing coronary artery bypass grafting surgery are associated with the interleukin-6-174G > C gene polymorphism.
    Wypasek E; Undas A; Sniezek-Maciejewska M; Kapelak B; Plicner D; Stepien E; Sadowski J
    Ann Clin Biochem; 2010 Jul; 47(Pt 4):343-9. PubMed ID: 20592333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.